[EN] SERINE/THREONINE PAK1 INHIBITORS<br/>[FR] INHIBITEURS DE SÉRINE/THRÉONINE PAK1
申请人:HOFFMANN LA ROCHE
公开号:WO2013026914A1
公开(公告)日:2013-02-28
Compounds having the formula I wherein A, Z, R1a, R1b, R2, R3, R4, R5, R6, R7, R9, R10, Ra, Rb and n are as defined herein are inhibitors of PAK1. Also disclosed are compositions and methods for treating cancer and hyperproliferative disorders.
NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS FOR OPIOID RECEPTORS
申请人:Diaz Caroline Jean
公开号:US20100222345A1
公开(公告)日:2010-09-02
This invention relates to novel compounds which are antagonists or inverse agonists at one or more of the opioid receptors, to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy.
[EN] PROLYL HYDROXYLASE INHIBITORS<br/>[FR] INHIBITEURS DE LA PROLYLHYDROXYLASE
申请人:SMITHKLINE BEECHAM CORP
公开号:WO2009134850A1
公开(公告)日:2009-11-05
The invention described herein relates to certain benzimidazol-4-ylcarboxamide derivatives of formula (I) which are antagonists of HIF prolyl hydroxylases and are useful for treating diseases benefiting from the inhibition of this enzyme, anemia being one example.
Bicyclic heteroaryl-substituted imidazoles as modulators of the histamine H4 receptor
申请人:Kindrachuk David E.
公开号:US20090156613A1
公开(公告)日:2009-06-18
Bicyclic heteroaryl-substituted imidazole compounds are described, which are useful as H
4
receptor modulators. Such compounds may be used in pharmaceutical compositions and methods for the modulation of histamine H
4
receptor activity and for the treatment of disease states, disorders, and conditions mediated by H
4
receptor activity, such as allergy, asthma, autoimmune diseases, and pruritis.
[EN] HETEROCYCLIC BENZIMIDAZOLES AS TRPM8 MODULATORS<br/>[FR] BENZIMIDAZOLES HÉTÉROCYCLIQUES EN TANT QUE MODULATEURS DE TRPM8
申请人:JANSSEN PHARMACEUTICA NV
公开号:WO2010045166A1
公开(公告)日:2010-04-22
Disclosed are compounds, compositions and methods for treating various diseases, syndromes, conditions and disorders, including pain. Such compounds are represented by Formula (I) as follows: wherein W1, W2, W3, R1, R1a, R2, R2a, R3, V, Q, and X are defined herein.